GIORDANI, JORDAN
 Distribuzione geografica
Continente #
NA - Nord America 2.532
AS - Asia 1.450
EU - Europa 1.229
SA - Sud America 319
Continente sconosciuto - Info sul continente non disponibili 105
AF - Africa 37
OC - Oceania 2
Totale 5.674
Nazione #
US - Stati Uniti d'America 2.446
SG - Singapore 670
IT - Italia 441
CN - Cina 291
BR - Brasile 258
DE - Germania 162
FI - Finlandia 140
HK - Hong Kong 125
VN - Vietnam 101
FR - Francia 76
GB - Regno Unito 73
IN - India 64
IE - Irlanda 61
TR - Turchia 54
RU - Federazione Russa 52
CA - Canada 41
BE - Belgio 34
SE - Svezia 33
UA - Ucraina 32
BD - Bangladesh 30
ID - Indonesia 26
PL - Polonia 26
AR - Argentina 25
JP - Giappone 18
MX - Messico 18
ZA - Sudafrica 18
NL - Olanda 16
AT - Austria 14
EC - Ecuador 11
ES - Italia 11
IQ - Iraq 11
PK - Pakistan 10
VE - Venezuela 10
MK - Macedonia 9
LT - Lituania 8
SA - Arabia Saudita 7
CR - Costa Rica 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
JM - Giamaica 5
MA - Marocco 5
NP - Nepal 5
AZ - Azerbaigian 4
EG - Egitto 4
GR - Grecia 4
HN - Honduras 4
JO - Giordania 4
PA - Panama 4
PE - Perù 4
PT - Portogallo 4
UZ - Uzbekistan 4
AL - Albania 3
BG - Bulgaria 3
BO - Bolivia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
IL - Israele 3
KE - Kenya 3
LV - Lettonia 3
NO - Norvegia 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CH - Svizzera 2
CY - Cipro 2
CZ - Repubblica Ceca 2
EU - Europa 2
KW - Kuwait 2
LK - Sri Lanka 2
MD - Moldavia 2
MU - Mauritius 2
PS - Palestinian Territory 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AU - Australia 1
BJ - Benin 1
BY - Bielorussia 1
CL - Cile 1
EE - Estonia 1
GE - Georgia 1
HR - Croazia 1
IR - Iran 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LY - Libia 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
PH - Filippine 1
PW - Palau 1
PY - Paraguay 1
RO - Romania 1
SI - Slovenia 1
SR - Suriname 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 5.570
Città #
Ashburn 356
Singapore 337
Chandler 228
San Jose 225
Brescia 168
New York 153
Hong Kong 123
Los Angeles 88
Fairfield 87
Helsinki 85
The Dalles 76
Beijing 74
Princeton 74
Munich 65
Lauterbourg 48
Wilmington 46
Milan 45
Seattle 44
Verona 43
Woodbridge 42
Turku 41
Dublin 40
Ho Chi Minh City 38
Istanbul 38
Dallas 36
Ann Arbor 34
Brussels 34
Cambridge 34
Council Bluffs 33
Shanghai 33
Columbus 32
Houston 31
São Paulo 27
Warsaw 25
Chicago 24
San Francisco 23
Santa Clara 23
Hanoi 22
Jakarta 22
Redondo Beach 21
Buffalo 19
Montreal 19
Moscow 19
Washington 18
Brooklyn 17
Chennai 16
Tokyo 16
Trento 16
Denver 15
Düsseldorf 15
Atlanta 14
Azzano 14
Jacksonville 14
Lappeenranta 14
Menlo Park 14
Orem 14
Phoenix 14
Boardman 13
Frankfurt am Main 12
London 12
Pune 12
San Diego 12
Des Moines 11
Johannesburg 10
Mumbai 9
Nuremberg 9
Rome 9
Sommacampagna 9
Stockholm 9
Poplar 8
Skopje 8
Ankara 7
Boston 7
Mexico City 7
Paris 7
Romola 7
Vienna 7
Belo Horizonte 6
Cazzago San Martino 6
Gunzenhausen 6
Kyiv 6
Portsmouth 6
San José 6
Amsterdam 5
Guangzhou 5
Hangzhou 5
Islington 5
Philadelphia 5
Bergamo 4
Gurugram 4
Kingston 4
Lima 4
Manchester 4
Piangipane 4
Riga 4
Rio de Janeiro 4
São João del Rei 4
Tashkent 4
Toronto 4
Augusta 3
Totale 3.579
Nome #
Evaluating the Emergency Department admission and hospitalization trend for COPD Exacerbation and time-dependent Particulate Matter exposure 171
Alpha1-antitrypsin deficiency: a twenty-five years' experience. 167
Impact of Particulate Matter on Emergency Department admissions and hospitalizations for COPD Exacerbation 161
A case of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) with thrombosis of the superior mesenteric artery after ChAdOx1 nCov-19 COVID-19 Vaccine 153
Effects of short-term exposure to Particulate Matter on Emergency Department admissions for Asthma Exacerbation 148
Consequences of SARS-COV-2 Pneumonia on Lung function 145
Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in COPD development? 140
Alpha1-antitrypsin deficiency and asthma 139
Emergency department admission and hospitalization for COPD exacerbation and particulate matter short-term exposure in Brescia, a highly polluted town in northern Italy 139
Predictors of exercise-induced airways obstruction in patients with mild asthma 135
Phenotyping OSAH patients during wakefulness 133
RETROSPECTIVE ANALYSIS AND RESULTS OF THE ALPHA1-ANTITRYPSIN DEFICIENCY CENTER ACTIVITY IN BRESCIA 132
Ultrasonographic Evaluation of Subglottic Stenoses: A Preliminary Analysis 131
Assessment of Small Airway Dysfunction and Z-Alpha1-Antitrypsin Polymers in Exhaled Breath Condensate in Healthy PiZZ Subjects 130
Emergency department visits for Asthma Exacerbation after short-term exposure to Particulate Matter: trend assessment in a European industrial city. 127
ASSESSMENT OF RESPIRATORY FUNCTION IN PATIENTS AFTER SARS-COV-2 LUNG DISEASE 127
Evaluating the Respiratory Function Impairments in Patients with Previous SARS-COV2 Pneumonia 125
Benralizumab therapy rapidly improved the quality of life in a woman with adult-onset non-allergic eosinophilic asthma 123
Diagnosing pneumothorax through standardized bilateral ultrasound images comparison 123
Late Breaking Abstract - Lung function tests in patients with previous SARS-COV2 pneumonia: a useful follow-up tool 121
Role Of Particulate Matter On Emergency Department Visits For Asthma Exacerbation 119
A Six-Month Follow-Up Evaluation of Lung Function in Patients with Previous SARS-COV-2 Pneumonia 119
Effects of short-term exposure to particulate matter on emergency department admission and hospitalization for asthma exacerbations in Brescia district 118
Alpha1-antitrypsin deficiency and cardiovascular disease: questions and issues of a debated relation 116
CHARACTERIZATION OF THE AIRWAY WALL COMPLIANCE AFTER TREATMENT WITH BRONCHODILATOR IN COPD PATIENTS 116
EVALUATION OF LUNG FUNCTION AFTER SARS-COV-2 PNEUMONIA 115
Evaluation of a New Strategy to Predict Exercise-Induced Asthma 114
SMALL AIRWAYS DISEASE AND Z-ALPHA1-ANTITRYPSIN POLYMERS: IS THERE A CORRELATION? 113
Time-Dependent Relationship Between Particulate Matter Exposure and COPD Exacerbations 112
Investigating the Link between Alpha-1 Antitrypsin Deficiency and Abdominal Aortic Aneurysms 112
Simplified Daytime Approach in OSAH Phenotyping 110
Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients 108
COPD EXACERBATION AND AIRBORNE POLLUTANTS: CHARACTERIZING THE ROLE OF PARTICULATE MATTER AND FINE PARTICULATE MATTER SHORT-TERM EXPOSURE 108
Assessment of respiratory function and exercise tolerance at 4-6 months after COVID-19 infection in patients with pneumonia of different severity 106
Short-Term Exposure to Particulate Matter and Asthma: A Link Between Environment and Respiratory Emergencies 102
PHENOTYPING PATIENTS WITH OSAH DURING WAKEFULNESS 101
Standardizing Bilateral Ultrasound Images Comparison for the Diagnosis of Pneumothorax: A Pilot Study 101
Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in alfa-1 anti-trypsin deficiency-related COPD development? 101
Long-term alveolar-capillary diffusion impairments after severe SARS-CoV-2 pneumonia 100
EXERCISE-INDUCED ASTHMA: RESEARCHING PREDICTORS IN SUBJECTS WITH MILD ASTHMA 100
CHARACTERIZATION OF THE IMPACT OF PARTICULATE MATTER AND FINE PARTICULATE MATTER ON ASTHMA EXACERBATION 100
SMALL AIRWAYS DISEASE AND Z-ALPHA1-ANTITRYPSIN POLYMERS: IS THERE A CORRELATION? 100
ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up 98
Sleep-disordered breathing and pregnancy outcomes: The impact of maternal oxygen saturation 91
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study 90
EXERCISE-INDUCED ASTHMA: RESEARCHING PREDICTORS IN SUBJECTS WITH MILD ASTHMA 85
Deficit Di Alfa-1 Antitripsina E Bpco: I Danni Del Ritardo Diagnostico 59
Evaluation of Long-Term Response to Biological Therapy in Severe Asthma and Considerations for Treatment Adjustment 50
24-Month assessment of respiratory function in patients hospitalized for severe SARS-CoV-2 pneumonia: a follow-up study 40
Totale 5.674
Categoria #
all - tutte 32.048
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.048


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022419 0 14 32 54 7 50 32 39 37 32 38 84
2022/2023599 51 77 31 47 35 115 2 110 55 0 20 56
2023/2024592 32 11 65 78 34 171 11 55 71 10 6 48
2024/20251.144 2 17 10 152 101 97 65 47 184 146 178 145
2025/20262.397 238 261 140 382 311 187 354 70 141 209 70 34
2026/2027109 68 41 0 0 0 0 0 0 0 0 0 0
Totale 5.674